MODERN APPROACHES TO THE TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN

Maxpiyeva Guldona Kabiljanovna

Authors

Maxpiyeva Guldona Kabiljanovna Andijan State Medical Institute, dotsent of the Department of Pediatrics for the Faculty of Medicine

Keywords:

asthma, wheezing, genes, infections, allergens.

Abstract

Bronchial asthma (BA) is one of the most common chronic diseases worldwide, affecting more than 100 million people. It occurs in all countries regardless of their level of development and represents a significant social problem for both children and adults. Bronchial asthma can develop at any age; however, in almost half of patients it begins in childhood, and in another 30% it develops before the age of 40. Women are more frequently affected by bronchial asthma. The prevalence of BA is associated with environmental deterioration, exposure to household allergens, and infectious diseases. The social significance of this problem and the economic burden caused by the disease are considerable for healthcare systems. One of the most important tasks of modern medicine is the improvement of methods for the diagnosis and treatment of asthma.

References

Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2007 revision). Translated from English, edited by A.G. Chuchalin. Moscow: Atmosfera Publishing House, 2008. 100 p.

Ovcharenko S.I. Bronchial asthma: diagnosis and treatment. Russian Medical Journal. 2002; No. 17: p. 766.

Knyazheskaya N.P., Potapova M.O. Diagnosis, classification, and principles of bronchial asthma treatment according to modern GINA-2002 recommendations. Difficult Patient. 2003; No. 3: p. 3.

Macharadze D.Sh. Bronchial asthma and osteoporosis: some aspects of modern therapy. Lechashchiy Vrach (Attending Physician). 2010; No. 6: pp. 52–55.

National Program “Bronchial Asthma in Children: Treatment Strategy and Prevention.” 3rd ed., revised and expanded. Moscow: Atmosfera Publishing House, 2008. 108 p.

Ledford D.K. Omalizumab: overview of pharmacology and efficacy in asthma. Expert Opinion on Biological Therapy. 2009; Vol. 9, No. 7: pp. 933–943.